Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
8 min read
KDELR3 Biologics Sequence Review Report 2026: ER lumen protein-retaining receptor 3 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of KDELR3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
HCRTR2 Biologics Sequence Review Report 2026: Orexin receptor type 2 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of HCRTR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
HCRTR1 Biologics Sequence Review Report 2026: Orexin/Hypocretin receptor type 1 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of HCRTR1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GALR2 Biologics Sequence Review Report 2026: Galanin receptor type 2 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GALR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GRID2 Biologics Sequence Review Report 2026: Glutamate receptor ionotropic, delta-2 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GRID2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
MLNR Biologics Sequence Review Report 2026: Motilin receptor Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of MLNR protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
FFAR2 Biologics Sequence Review Report 2026: Free fatty acid receptor 2 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of FFAR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
P2RX6 Biologics Sequence Review Report 2026: P2X purinoceptor 6 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of P2RX6 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GRIN2D Biologics Sequence Review Report 2026: Glutamate receptor ionotropic, NMDA 2D Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GRIN2D protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GRM6 Biologics Sequence Review Report 2026: Metabotropic glutamate receptor 6 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GRM6 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
LEPROT Biologics Sequence Review Report 2026: Leptin receptor gene-related protein Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of LEPROT protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
EPHB6 Biologics Sequence Review Report 2026: Ephrin type-B receptor 6 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of EPHB6 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
587
588
589
590
591
>>
1905
>